DUBLIN–(BUSINESS WIRE)–The “Biomedical and ICT Convergence Market by Technology, Solution and Region 2021-2026” report has been added to ResearchAndMarkets.com’s offering.
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies.
Select Report Findings:
- The biomedical ICT market is expected to reach $64 billion USD by 2026
- North America will lead the biomedical ICT market during the forecasted period
- The hardware technology will represent over 49% of the biomedical ICT market by 2026
- Diagnostic and research will be the prime application area within the biomedical ICT market
- Biomedical and ICT convergence is the foundation for the preponderance of biomedical technology
The field of biomedicine is concerned with the application of various natural science disciplines for the development of knowledge, interventions, and/or technologies for use in healthcare. The Information and Communications Technology (ICT) sector focuses on telecommunications, computing, and the integration of both.
The convergence of biomedical and ICT represents a high opportunity area for both healthcare and ICT industries. In addition to seeking cures to disease and ailment prevention, combined biomedical and ICT solutions will lead to improved treatment efficacy as well as overall improvements in healthcare service delivery efficiency and effectiveness.
With healthcare costs growing much faster than the general inflation rate, it is of the utmost importance to simultaneously seek improved treatment while continuously driving down business costs. These costs include ongoing operational expenditures aswell as expensive R&D such as drug discovery and other pharmaceutical-related areas such as vaccine development that takes into account precision medicine practices.
Various ICT tools may be employed such as IoT enabled monitoring to determine the effectiveness of medical procedures, which can be especially important when administering new and unproven healthcare modalities. One specific example is the administration of vaccines, which is believed to potentially cause harm to a subset of the population based on epigenetics, which is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself.
One of the fastest-growing areas for ICT in healthcare is the use of wireless access by IP-enabled, handheld digital devices. Wearables and implantable technology hold the promise of a level of monitoring and healthcare administration that is unprecedented in the history of health science. Ranging from treatment administration to clinical decision support, connected devices are a rapidly evolving tool for the advancement of healthcare practices.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Biomedical Technology
2.2 Biomedical and ICT Convergence
2.3 Biotechnology vs. Biomedical Technology
2.4 Biomedicine
2.5 Market Trends
3. Biomedical and ICT Technologies and Solutions
3.1 Technology Analysis
3.1.1 Biomedical Diagnostics Devices
3.1.2 Bionanotechnology
3.1.3 Temperature Sensors
3.1.4 Refrigerators and Freezers
3.1.5 Metal Equipment
3.1.6 Software Technology and ICT Services
3.2 Biomedical and ICT Application Analysis
3.2.1 Diagnostics and Research Solution
3.2.2 Tissue Engineering and Regeneration
3.2.3 Fermentation
3.2.4 Cell Based Assay
3.2.5 PCR Technology
3.2.6 Chromatography
3.2.7 Additive Metal Solution
3.3 Cloning and Somatic Cell Nuclear Transfer
3.4 Industry Specific Uses
3.4.1 Medical, Pharmaceutical, and Health
3.4.2 Food and Agriculture
3.4.3 Natural Resources and Environment
3.4.4 Industrial Processing
3.4.5 Bioinformatics
3.5 Cloud Deployment and IT Infrastructure Management
4. Company Analysis
4.1 Abbott Laboratories
4.2 Amgen Inc.
4.3 Analog Devices
4.4 AstraZeneca
4.5 Biogen
4.6 Bio-Rad Laboratories
4.7 Biodirection
4.8 BioTelemetry
4.9 Carpenter Technology
4.10 Celgene Corporation
4.11 Dentsply Sirona
4.12 First Sensor
4.13 GE Healthcare
4.14 Gilead Sciences
4.15 Haier Biomedical
4.16 Helmer Scientific
4.17 Hoffman-La Roche Ltd.
4.18 Honeywell
4.19 Johnson & Johnson
4.20 Lonza Group
4.21 Medtronic
4.22 Merck & Co
4.23 Nonin Medical
4.24 Novartis AG
4.25 Novo Nordisk
4.26 NXP Semiconductor
4.27 Panasonic
4.28 Pfizer Inc.
4.29 Sanofi Aventis
4.30 Smiths Medical Inc.
4.31 STMicroelectronics
4.32 TE Connectivity
4.33 Texas Instruments
4.34 Thermo Fisher
4.35 Wright Medical Group
4.36 Zimmer Biomet
5. Biomedical ICT Market Analysis and Forecast 2021 – 2026
5.1 Global Biomedical ICT Market 2021 – 2026
5.1.1 Aggregate Market 2021 – 2026
5.1.2 Market by Technology 2021 – 2026
5.1.2.1 Market by Hardware 2021 – 2026
5.1.2.2 Market by Software 2021 – 2026
5.1.2.3 Market by Service 2021 – 2026
5.1.3 Market by Solution 2021 – 2026
5.1.3.1 Market by Diagnostics and Research Solution 2021 – 2026
5.1.3.2 Market by Biomedical Metal Solution 2021 – 2026
5.1.4 Market by Industry Vertical 2021 – 2026
5.1.5 Market by Cloud Deployment 2021 – 2026
5.2 Regional Biomedical ICT Market 2021 – 2026
6. Conclusions and Recommendations
7. Appendix: Connected Medical Device Market Analysis and Forecasts
7.1 Connected Medical Device Market Drivers
7.1.1 Connected Health and Telemedicine
7.1.2 Wearable Healthcare Devices
7.1.3 Specialized Healthcare Devices
7.2 Global Connected Medical Device Market Outlook
7.3 Connected Medical Device Market by Manufacturing Method 2021 – 2026
7.4 Connected Medical Device Market by Location/ Usage 2021 – 2026
7.5 Connected Medical Device Market by Delivery/Acquisition 2021 – 2026
7.6 Connected Medical Device Market by Risk Classification 2021 – 2026
7.7 Connected Medical Device Market by Industry Sub-sector 2021 – 2026
7.8 Connected Medical Device Market by Key Therapeutic Segments 2021 – 2026
7.9 Connected Medical Device Market by Connectivity Method
7.10 Connected Medical Device Markets by Region 2021 – 2026
For more information about this report visit https://www.researchandmarkets.com/r/suq4g9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900